pI: 5.0011 |
Length (AA): 272 |
MW (Da): 28825 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
45 | 102 | 2mqa (A) | 40 | 97 | 21.00 | 0 | 0.08 | 0.494135 | -0.89 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_129067)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G51620 | hypothetical protein |
Arabidopsis thaliana | AT5G55940 | protein EMBRYO DEFECTIVE 2731 |
Brugia malayi | Bm1_50115 | Hypothetical UPF0172 protein CG3501 |
Caenorhabditis elegans | CELE_F25H2.4 | Protein F25H2.4 |
Cryptosporidium hominis | Chro.70366 | hypothetical protein |
Cryptosporidium parvum | cgd7_3280 | JAB domain containing protein |
Dictyostelium discoideum | DDB_G0268048 | UPF0172 protein |
Drosophila melanogaster | Dmel_CG3501 | CG3501 gene product from transcript CG3501-RA |
Echinococcus granulosus | EgrG_000673100 | Neighbor of COX4 |
Echinococcus multilocularis | EmuJ_000673100 | Neighbor of COX4 |
Homo sapiens | ENSG00000100908 | ER membrane protein complex subunit 9 |
Homo sapiens | ENSG00000131148 | ER membrane protein complex subunit 8 |
Leishmania braziliensis | LbrM.07.0300 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_070450.1 | Uncharacterised protein family (UPF0172), putative |
Leishmania infantum | LinJ.07.0450 | hypothetical protein, conserved |
Leishmania major | LmjF.07.0290 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.07.0290 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_02814 | hypothetical protein |
Mus musculus | ENSMUSG00000031819 | ER membrane protein complex subunit 8 |
Mus musculus | ENSMUSG00000022217 | ER membrane protein complex subunit 9 |
Neospora caninum | NCLIV_065510 | hypothetical protein, conserved |
Oryza sativa | 4335339 | Os04g0270200 |
Onchocerca volvulus | OVOC501 |
|
Plasmodium berghei | PBANKA_0909100 | conserved protein, unknown function |
Plasmodium falciparum | PF3D7_1139900 | conserved protein, unknown function |
Plasmodium knowlesi | PKNH_0937800 | conserved protein, unknown function |
Plasmodium vivax | PVX_092595 | conserved protein, unknown function |
Schistosoma japonicum | Sjp_0069190 | Neighbor of COX4, putative |
Schistosoma mansoni | Smp_043880.2 | hypothetical protein |
Trypanosoma brucei gambiense | Tbg972.8.1180 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.8.1570 | Uncharacterised protein family (UPF0172), putative |
Trypanosoma congolense | TcIL3000_8_1400 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.508547.180 | Uncharacterised protein family (UPF0172), putative |
Toxoplasma gondii | TGME49_249310 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.1570 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.1570 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.1570 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.1570 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F25H2.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F25H2.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F25H2.4 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F25H2.4 | Caenorhabditis elegans | terminal arrest variable | wormbase |
TGME49_249310 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.